热门资讯> 正文

Inovio Pharmaceuticals股价下跌6%，提议进行股权发行

2025-11-11 14:33

伊诺维奥制药(INO) 0

Inovio Pharmaceuticals (INO) proposed an underwritten public offering of its common stock, with all shares in the offering to be sold by the company itself.
The underwriters have a 30-day option to purchase up to 15% additional shares.
The offering’s completion, size, and terms will depend on market conditions, and there is no guarantee as to its eventual execution or pricing.
The stock price traded ~6% lower on Tuesday during pre-market trade.

More on Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. 2025 Q3 - Results - Earnings Call Presentation
Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)
Inovio outlines mid-2026 launch for INO-3107 as BLA submission progresses
Inovio Pharmaceuticals GAAP EPS of -$0.87 misses by $0.45

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。